(Q41138686)

27 September 2017

HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein (English)

1 reference

27 September 2017

Jia Chen

1

1 reference

27 September 2017

James M Kovacs

2

1 reference

27 September 2017

Hanqin Peng

3

1 reference

27 September 2017

Sophia Rits-Volloch

4

1 reference

27 September 2017

Jianming Lu

5

1 reference

27 September 2017

Donghyun Park

6

1 reference

27 September 2017

Elise Zablowsky

7

1 reference

27 September 2017

Michael S Seaman

8

1 reference

27 September 2017

Bing Chen

9

1 reference

27 September 2017

language of work or name

English

0 references

publication date

25 June 2015

1 reference

27 September 2017

1 reference

27 September 2017

349

1 reference

27 September 2017

6244

1 reference

27 September 2017

191-195

1 reference

A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Development of prophylactic vaccines against HIV-1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Neutralizing antibodies to HIV-1 induced by immunization.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

27 September 2017

Viral membrane fusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Atomic structure of the ectodomain from HIV-1 gp41

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Core structure of gp41 from the HIV envelope glycoprotein

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701381

Crystal Structure of HIV-1 Primary Receptor CD4 in Complex with a Potent Antiviral Antibody

19 August 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Role of Fc-mediated antibody function in protective immunity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

HIV entry and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Mechanics of membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Broad neutralization coverage of HIV by multiple highly potent antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA9804

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.AAA9804

1 reference

27 September 2017

1 reference

27 September 2017

PubMed publication ID

26113642

1 reference